Pyridine carbamates and their use as GLUN2B receptor modulators | Patent Number 11447503

US 11447503 B2
Application Number16899809
Publication NumberUS 20200392154 A1
Pendency2 years, 3 months, 10 days
Filled DateJun 12, 2020
Priority DateJun 14, 2019
Publication DateDec 17, 2020
Expiration DateJun 13, 2039
Inventor/ApplicantsHeather COATE
Curt DVORAK
Brice Stenne
Curt Dvorak
Brice STENNE
Christine GELIN
Christine Gelin
Heather Coate
ExaminesHAVLIN, ROBERT H
Art Unit1639
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.